MedPath
NMPA Approval

Indobufen Tablets

国药准字H20244907

September 19, 2024

Drug Information

吲哚布芬片

片剂

0.2g

化学药品

September 19, 2024

Company Information

Applicant Company

山东省泰安市高新技术产业开发区配天门大街西首

Manufacturing Company

山东省泰安高新技术产业开发区配天门大街西首

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吲哚布芬片 - NMPA 批准文号 | MedPath